Keywords: operating, profit, up, novo, nordisk, denmark, reported
Operating profit up 34% at Novo Nordisk
Article | 15 August 2000
Denmark's Novo Nordisk has reported a 22% (12% in local currencies) jumpin consolidated sales to 12.02 billion Danish kroner ($1.46 billion) for the first ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
